S
Scott D. Ramsey
Researcher at Fred Hutchinson Cancer Research Center
Publications - 509
Citations - 25573
Scott D. Ramsey is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 70, co-authored 469 publications receiving 22756 citations. Previous affiliations of Scott D. Ramsey include University of Washington Medical Center & Institute for Systems Biology.
Papers
More filters
Journal ArticleDOI
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Asad Umar,C. Richard Boland,Jonathan P. Terdiman,Sapna Syngal,Albert de la Chapelle,Josef Rüschoff,Richard Fishel,Noralane M. Lindor,Lawrence J. Burgart,Richard Hamelin,Stanley R. Hamilton,Robert A. Hiatt,Jeremy R. Jass,Annika Lindblom,Henry T. Lynch,Päivi Peltomäki,Scott D. Ramsey,Miguel A. Rodriguez-Bigas,Hans F. A. Vasen,Ernest T. Hawk,J. Carl Barrett,Andrew N. Freedman,Sudhir Srivastava +22 more
TL;DR: This commentary summarizes the Workshop presentations on HNPCC and MSI testing; presents the issues relating to the performance, specificity, and specificity of the Bethesda Guidelines; outlines the revised Bethesda Guidelines for identifying individuals at risk for H NPCC; and recommend criteria for MSI testing.
Journal ArticleDOI
Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial
Karen Kelly,John Crowley,Paul A. Bunn,Cary A. Presant,Patra K. Grevstad,Carol M. Moinpour,Scott D. Ramsey,Antoinette J. Wozniak,Geoffrey R. Weiss,Dennis F. Moore,Valerie Israel,Robert B. Livingston,David R. Gandara +12 more
TL;DR: PC is equally efficacious as VC for the treatment of advanced non--small-cell lung cancer, and overall costs on the PC arm were higher than on the VC arm because of drug costs.
Journal ArticleDOI
The case for early detection
Ruth Etzioni,Nicole Urban,Scott D. Ramsey,Martin W. McIntosh,Stephen M. Schwartz,Brian J. Reid,Jerald P. Radich,Garnet L. Anderson,Leland H. Hartwell +8 more
TL;DR: Research has recently been revitalized by the advent of novel molecular technologies that can identify cellular changes at the level of the genome or proteome, but how can these new technologies be harnessed to develop effective and practical screening tests?
Journal ArticleDOI
Incidence, outcomes, and cost of foot ulcers in patients with diabetes.
Scott D. Ramsey,Katherine M. Newton,David K. Blough,David K. McCulloch,Nirmala Sandhu,Gayle E. Reiber,Edward H. Wagner +6 more
TL;DR: The results appear to support the value of foot-ulcer prevention programs for patients with diabetes and the attributable cost of care compared with that in patients without foot ulcers.
Journal ArticleDOI
Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report
Scott D. Ramsey,Richard J. Willke,Andrew Briggs,Ruth E. Brown,Martin Buxton,Anita Chawla,John R. Cook,Henry A. Glick,Bengt Liljas,Diana B. Petitti,Shelby D. Reed +10 more
TL;DR: Trial-based cost-effectiveness studies have appeal because of their high internal validity and timeliness and improving the quality and uniformity of these studies will increase their value to decision makers who consider evidence of economic value along with clinical efficacy when making resource allocation decisions.